FDA Approves Irinotecan Liposome to Treat Pancreatic Cancer



Patients with metastatic pancreatic cancer that has progressed after receiving gemcitabine-based chemotherapy now have a new treatment option: irinotecan liposome in combination with fluorouracil and leucovorin.



Source link

Comments are closed.